The efficacy and safety of intrathecal dexmedetomidine for parturients undergoing cesarean section: a double-blind randomized controlled trial

Table 4 Neonatal outcomes

	Group B (n = 100)	Group FB (n = 100)	Group DB (n = 100)	P-Value
Umbilical artery
pH	7.3 ± 0.3	7.3 ± 0.2	7.3 ± 0.4	0.581
PaO₂ (mmHg)	15.6 ± 2.0	15.0 ± 2.3	15.4 ± 2.4	0.217
PaCO₂ (mmHg)	49.9 ± 3.4	49.8 ± 4.0	50.4 ± 4.6	0.545
Umbilical vein
pH	7.4 ± 0.2	7.4 ± 0.1	7.4 ± 0.5	0.711
PaO₂ (mmHg)	30.0 ± 3.4	30.7 ± 4.4	30.80 ± 3.5	0.277
PaCO₂ (mmHg)	42.6 ± 3.2	41.6 ± 3.8	42.0 ± 3.2	0.111
Apgar score
1 min	8.7 ± 0.5	8.7 ± 0.5	8.7 ± 0.5	0.752
5 min	9.7 ± 0.5	9.7 ± 0.4	9.7 ± 0.5	0.809

Notes: Data are presented as mean ± SD; Group B = bupivacaine group; Group FB = bupivacaine and fentanyl group; Group DB = bupivacaine and dexmedetomidine group
*P < 0.017 Group DB or Group FB vs Group B; ^#P < 0.017 Group DB vs Group FB

ISSN: 1471-2253